All about COVID-19

A COVID-19 control plan made simple

The COVID-19 outbreak is not yet an epidemic in India — as of today. From what is happening globally, a huge epidemic, an avalanche, growing bigger week after week, is predictable. Today it is a crisis looming on the horizon, but tomorrow it may turn out to be a disaster of unprecedented proportions.

The track record

Culturally we are always optimistic; we do not react fast as most problems, even outbreaks, have a tendency to settle down. So far we have stoically confronted all the new and resurgent communicable diseases that appeared in recent decades. We have shown surge capacity of crisis management during the 2018 Nipah epidemic in Kerala. We handled the Severe Acute Respiratory Syndrome (SARS) scare of 2003 extremely efficiently. The 2009 pandemic influenza H1N1 was also confronted reasonably well. Our weakness in dealing with seasonal influenza is embarrassing: there is no national policy to control seasonal flu. We ignore the high flu death rates reported annually. We manage short-term crisis very well but not long-term disease control — like running a short sprint but with no stamina to go on running a marathon.

Also read | COVID-19 now a pandemic, says WHO; India confirms 60 cases

From early February the reality of a very unusual SARS COVID-19 epidemic was known to all Health Ministry officers. In early January only China was known to have the coronavirus, but today more than 100 countries are affected. That speed is about the same as that of the pandemic influenza H1N1 of 2009.

What comes first

The onerous responsibility of confronting SARS COVID-19 does not rest with the Union Health Secretary who is the administrative head of the Ministry of Health and Family Welfare. It does not rest with the Director of the National Centre for Disease Control (NCDC) unless specifically empowered; The NCDC functions well only when smaller problems erupt in various States. The Director General of Health Services (DGHS) could be the person, but epidemic control is more than health-care service. The DGHS has limited executive powers and there is no competent public health infrastructure under the Directorate. The job of the Department of Health Research and the Indian Council of Medical Research (ICMR) under the unified command of the Secretary Department of Health Research-cum-DG ICMR, is to research all questions identified by the DGHS and the Director of the NCDC. We do need research but priority number one is the control of the epidemic.

The Minister for Health is a key person but this epidemic is more than a medical problem. Many ministries such as those of travel, tourism, industry, education, economics, railways and local governments are all being affected. So this disease avalanche requires responses of unprecedented speed, spread and magnitude.

Also read | What is a pandemic?

All officials listed above have a hundred and one things on their minds all the time. India needs a dedicated disaster management operation for this epidemic. The one person who can, and must, take immediate responsibility and manage the crisis the best possible way is none other than the Prime Minister himself. The Prime Minister should declare a national emergency and establish a ‘war-machinery’, with a ‘task force’ of the best experts in the country, of proven capability and track record against communicable diseases.

The war room should have all necessary facilities and should run a 24-hour control room. The support of the Ministers of all the relevant Ministries and their officers should be accessible to the task force. The job of the task force ought to have one goal: manage the epidemic, to minimise the spread and damage of the virus, and to mitigate the sufferings of all people everywhere.

COVID-19 | ‘Heat is not a deterrent for transmission’: Your COVID-19 queries answered

Once the task force designs a strategy with tactics, the Ministry of Health as well as all Ministries must implement them. The terms of reference of the task force must include the design of immediate, short-term, medium-term and long-term responses. The absence of such an empowered agency has had serious repercussions.

The slip-ups

International airports were instructed by the Ministry concerned to screen all passengers arriving from China. That was fine and towards January-end and early-February, two individuals returning from Wuhan, China, to Kerala were detected to be infected with “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)”. The time to establish a national agency such as the task force to advise the government on all necessary interventions was immediately thereafter. A 24-hour control room should have been operational by the second week of February. The infection was rapidly expanding in various countries. Shortly thereafter some 24 countries outside China, Hong Kong and Macau were known to be infected. When was Italy identified as a potential source of virus in travellers? On February 20, the following countries had reported over 20 infections: Japan, Thailand, Singapore, South Korea and Taiwan. Italy was not in that list.

COVID-19 | Interactive map of confirmed coronavirus cases in India

The next day Italy had 20 cases; thereafter the daily numbers were 79, 155, 229 and 322. Italy was identified as a potential source for screening of air travellers only on March 1. On February 29 a family travelling from Italy to Kerala did not fall within the screening net. That flaw resulted in a cluster of cases in Kerala — Italy should have been identified as a potential source on February 22 when the number of cases jumped from 20 to 79. All existing agencies and officers have many responsibilities. An agency exclusively for managing a constant and continuous watch on all developments — biomedical and sociological — and to recommend remedial and containment measures is essential in order to face this epidemic.

Public education must be technically correct and timely. Only one agency should be the source of all information; the cacophony prevalent now must be curbed. The ball is in the Prime Minister’s court.

Dr. T. Jacob John, a retired doctor from CMC Vellore, is Chairman, Rotary Club of Vellore TB Control Society

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Apr 17, 2021 11:32:42 PM |

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
You are reading
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story